McDermott Will & Emery represented Iron Path Capital, while Spilman Thomas & Battle represented Chemours in the transaction. PureTech Scientific announced the acquisition of The Chemours Company’s...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented Vytalize Health in the transaction. Vytalize Health, a leading risk-bearing provider enablement platform, announced its acquisition of Independent Physician Association of...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented Amulet Capital Partners in the transaction. Amulet Capital Partners, a middle-market private equity investment firm focused exclusively on the healthcare sector,...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented Iron Path Capital in the transaction. Iron Path Capital, a private equity firm focused on healthcare and specialty industrials, announced its...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented Quad-C Management in the transaction. Quad-C Management, a leading middle market private equity firm, executed its investment in U.S. Endodontics Partners,...
You must be a Standard 1 Year member to access this content.
